Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature

키워드

참고문헌 (20)

1. Saif MW, "Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature", JOP, 6, pp.369~374 (2005)
2. Humphreys BD, "Gemcitabine-associated thrombotic microangiopathy", Cancer, 100, pp.2664~2670 (2004)
3. 박윤정, "Gemcitabine을 사용한 폐암환자에서 발생한 용혈성 요독증후군 1예", Tuberculosis and Respiratory Diseases, 72(2), pp.207~211 (2012), 대한결핵및호흡기학회
4. Gasser C, "Hemolyticuremic syndrome:bilateral necrosis of the renal cortex in acute acquired hemolytic anemia", Schweiz Med Wochenschr, 85, pp.905~909 (1955)
5. Gross M, "Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine", Anticancer Drugs, 10, pp.533~536 (1999)
6. Sadjadi SA, "Gemcitabine induced hemolytic uremic syndrome", Am J Case Rep, 13, pp.89~91 (2012)
7. Lewin SN, "Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin", Gynecol Oncol, 97, pp.228~233 (2005)
8. Jacquin JP, "Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients", Am J Clin Oncol, 35, pp.18~21 (2012)
9. Fung MC, "A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy", Cancer, 85, pp.2023~2032 (1999)
10. Lhotta K, "Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy", Am J Nephrol, 19, pp.590~593 (1999)
11. Flombaum CD, "Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine", Am J Kidney Dis, 33, pp.555~562 (1999)
12. Casper ES, "Phase II trial of gemcitabine (2,2’-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas", Invest New Drugs, 12, pp.29~34 (1994)
13. De Smet D, "Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine", Ann Hematol, 87, pp.495~496 (2008)
14. Boeck S, "Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer", J Clin Gastroenterol, 42, pp.551~552 (2008)
15. Wato M, "A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer", Nihon Shokakibyo Gakkai Zasshi, 107, pp.1676~1685 (2010)
16. Walter RB, "Gemcitabine-associated hemolytic-uremic syndrome", Am J Kidney Dis, 40, pp.E16~ (2002)
17. Glezerman I, "Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution", Clin Nephrol, 71, pp.130~139 (2009)
18. Gore EM, "Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome?", J Clin Apher, 24, pp.209~214 (2009)
19. Serke S, "Elevated reticulocyte count: a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report", Br J Cancer, 79, pp.1519~1521 (1999)
20. Bharthuar A, "Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report", Cancer Chemother Pharmacol, 64, pp.177~181 (2009)

관련 논문AI추천